Nello Blaser1, Cindy Zahnd1, Sabine Hermans2, Luisa Salazar-Vizcaya1, Janne Estill1, Carl Morrow3, Matthias Egger4, Olivia Keiser5, Robin Wood6. 1. Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland. 2. Desmond Tutu HIV Centre, Institute for Infectious Disease & Molecular Medicine, University of Cape Town, South Africa; Department of Global Health, Academic Medical Center, University of Amsterdam, Amsterdam Institute for Global Health and Development,The Netherlands; Department of Internal Medicine, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda. 3. Desmond Tutu HIV Centre, Institute for Infectious Disease & Molecular Medicine, University of Cape Town, South Africa. 4. Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland; School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa. 5. Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland. Electronic address: olivia.keiser@ispm.unibe.ch. 6. Desmond Tutu HIV Centre, Institute for Infectious Disease & Molecular Medicine, University of Cape Town, South Africa; Department of Medicine, University of Cape Town,, South Africa; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, UK.
Abstract
BACKGROUND: Tuberculosis (TB) is the leading cause of death in South Africa. The burden of disease varies by age, with peaks in TB notification rates in the HIV-negative population at ages 0-5, 20-24, and 45-49 years. There is little variation between age groups in the rates in the HIV-positive population. The drivers of this age pattern remain unknown. METHODS: We developed an age-structured simulation model of Mycobacterium tuberculosis (Mtb) transmission in Cape Town, South Africa. We considered five states of TB progression: susceptible, infected (latent TB), active TB, treated TB, and treatment default. Latently infected individuals could be re-infected; a previous Mtb infection slowed progression to active disease. We further considered three states of HIV progression: HIV negative, HIV positive, on antiretroviral therapy. To parameterize the model, we analysed treatment outcomes from the Cape Town electronic TB register, social mixing patterns from a Cape Town community and used literature estimates for other parameters. To investigate the main drivers behind the age patterns, we conducted sensitivity analyses on all parameters related to the age structure. RESULTS: The model replicated the age patterns in HIV-negative TB notification rates of Cape Town in 2009. Simulated TB notification rate in HIV-negative patients was 1000/100,000 person-years (pyrs) in children aged <5 years and decreased to 51/100,000 in children 5-15 years. The peak in early adulthood occurred at 25-29 years (463/100,000 pyrs). After a subsequent decline, simulated TB notification rates gradually increased from the age of 30 years. Sensitivity analyses showed that the dip after the early adult peak was due to the protective effect of latent TB and that retreatment TB was mainly responsible for the rise in TB notification rates from the age of 30 years. CONCLUSION: The protective effect of a first latent infection on subsequent infections and the faster progression in previously treated patients are the key determinants of the age-structure of TB notification rates in Cape Town.
BACKGROUND:Tuberculosis (TB) is the leading cause of death in South Africa. The burden of disease varies by age, with peaks in TB notification rates in the HIV-negative population at ages 0-5, 20-24, and 45-49 years. There is little variation between age groups in the rates in the HIV-positive population. The drivers of this age pattern remain unknown. METHODS: We developed an age-structured simulation model of Mycobacterium tuberculosis (Mtb) transmission in Cape Town, South Africa. We considered five states of TB progression: susceptible, infected (latent TB), active TB, treated TB, and treatment default. Latently infected individuals could be re-infected; a previous Mtb infection slowed progression to active disease. We further considered three states of HIV progression: HIV negative, HIV positive, on antiretroviral therapy. To parameterize the model, we analysed treatment outcomes from the Cape Town electronic TB register, social mixing patterns from a Cape Town community and used literature estimates for other parameters. To investigate the main drivers behind the age patterns, we conducted sensitivity analyses on all parameters related to the age structure. RESULTS: The model replicated the age patterns in HIV-negative TB notification rates of Cape Town in 2009. Simulated TB notification rate in HIV-negative patients was 1000/100,000 person-years (pyrs) in children aged <5 years and decreased to 51/100,000 in children 5-15 years. The peak in early adulthood occurred at 25-29 years (463/100,000 pyrs). After a subsequent decline, simulated TB notification rates gradually increased from the age of 30 years. Sensitivity analyses showed that the dip after the early adult peak was due to the protective effect of latent TB and that retreatment TB was mainly responsible for the rise in TB notification rates from the age of 30 years. CONCLUSION: The protective effect of a first latent infection on subsequent infections and the faster progression in previously treated patients are the key determinants of the age-structure of TB notification rates in Cape Town.
Authors: Robin Wood; Keren Middelkoop; Landon Myer; Alison D Grant; Andrew Whitelaw; Stephen D Lawn; Gilla Kaplan; Robin Huebner; James McIntyre; Linda-Gail Bekker Journal: Am J Respir Crit Care Med Date: 2006-09-14 Impact factor: 21.405
Authors: N K Sewankambo; R H Gray; S Ahmad; D Serwadda; F Wabwire-Mangen; F Nalugoda; N Kiwanuka; T Lutalo; G Kigozi; C Li; M P Meehan; H Brahmbatt; M J Wawer Journal: AIDS Date: 2000-10-20 Impact factor: 4.177
Authors: Elizabeth L Corbett; Catherine J Watt; Neff Walker; Dermot Maher; Brian G Williams; Mario C Raviglione; Christopher Dye Journal: Arch Intern Med Date: 2003-05-12
Authors: Saskia den Boon; Schalk W P van Lill; Martien W Borgdorff; Donald A Enarson; Suzanne Verver; Eric D Bateman; Elvis Irusen; Carl J Lombard; Neil W White; Christine de Villiers; Nulda Beyers Journal: Emerg Infect Dis Date: 2007-08 Impact factor: 6.883
Authors: Sara Suliman; Anele Gela; Simon C Mendelsohn; Sarah K Iwany; Kattya Lopez Tamara; Simbarashe Mabwe; Nicole Bilek; Fatoumatta Darboe; Michelle Fisher; Alexandra J Corbett; Lars Kjer-Nielsen; Sidonia B G Eckle; Chuan-Chin Huang; Zibiao Zhang; David M Lewinsohn; James McCluskey; Jamie Rossjohn; Mark Hatherill; Segundo R León; Roger I Calderon; Leonid Lecca; Megan Murray; Thomas J Scriba; Ildiko Van Rhijn; D Branch Moody Journal: J Infect Dis Date: 2020-08-17 Impact factor: 5.226
Authors: Sara Suliman; Ethan G Thompson; Jayne Sutherland; January Weiner; Martin O C Ota; Smitha Shankar; Adam Penn-Nicholson; Bonnie Thiel; Mzwandile Erasmus; Jeroen Maertzdorf; Fergal J Duffy; Philip C Hill; E Jane Hughes; Kim Stanley; Katrina Downing; Michelle L Fisher; Joe Valvo; Shreemanta K Parida; Gian van der Spuy; Gerard Tromp; Ifedayo M O Adetifa; Simon Donkor; Rawleigh Howe; Harriet Mayanja-Kizza; W Henry Boom; Hazel M Dockrell; Tom H M Ottenhoff; Mark Hatherill; Alan Aderem; Willem A Hanekom; Thomas J Scriba; Stefan H E Kaufmann; Daniel E Zak; Gerhard Walzl Journal: Am J Respir Crit Care Med Date: 2018-05-01 Impact factor: 30.528
Authors: Fergal J Duffy; Gregory S Olson; Elizabeth S Gold; Ana Jahn; Alan Aderem; John D Aitchison; Alissa C Rothchild; Alan H Diercks; Johannes Nemeth Journal: J Infect Dis Date: 2022-05-16 Impact factor: 7.759
Authors: Richard Baguma; Adam Penn-Nicholson; Erica Smit; Mzwandile Erasmus; Jonathan Day; Lebohang Makhethe; Marwou de Kock; E Jane Hughes; Michele van Rooyen; Bernadette Pienaar; Lynnett Stone; Willem Hanekom; Michael J Brennan; Robert S Wallis; Mark Hatherill; Thomas J Scriba Journal: PLoS One Date: 2017-09-08 Impact factor: 3.240
Authors: Stewart T Chang; Violet N Chihota; Katherine L Fielding; Alison D Grant; Rein M Houben; Richard G White; Gavin J Churchyard; Philip A Eckhoff; Bradley G Wagner Journal: BMC Med Date: 2018-04-12 Impact factor: 8.775
Authors: Piotr Hippner; Tom Sumner; Rein Mgj Houben; Vicky Cardenas; Anna Vassall; Fiammetta Bozzani; Don Mudzengi; Lindiwe Mvusi; Gavin Churchyard; Richard G White Journal: PLoS One Date: 2019-01-25 Impact factor: 3.240
Authors: Erasto V Mbugi; Bugwesa Z Katale; Athumani M Lupindu; Julius D Keyyu; Sharon L Kendall; Hazel M Dockrell; Anita L Michel; Mecky I Matee; Paul D van Helden Journal: East Afr Health Res J Date: 2017-03-01